// App-Quantinova.ai

3791 : TRPV6 calcium channel peptide antagonists as novel antimyeloma and antiresorptive agents

Researchers

Presenter

  • Alli Murugesan

Principal Investigators

  • Philippe Tremblay

  • Ming Han

  • Bithika Ray

  • Tyler Lutes

  • Tony Reiman

Medical Centers

  • University of New Brunswick, Saint John, New Brunswick, Canada

  • Dalhousie University, Halifax, Nova Scotia, Canada.

  • Soricimed Biopharma Inc, Sackville, New Brunswick, Canada

  • Saint John Regional Hospital, Horizon Health Network, Saint John, New Brunswick, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

  • Urology

Disease

  • Multiple Myeloma

  • Unspecified Cancer

  • Prostate cancer

  • Solid malignancies

  • Twin-reversed arterial perfusion

Biomarkers

  • Cathepsin X

  • Syndecan-1

  • Triiodothyronine receptor auxiliary protein

Drug/Treatment

  • SOR-C13

  • SORC27

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved